Ferdinand E. Massari
Directeur/Membre du Conseil chez Clinical Trials Management Group, Inc.
Profil
Ferdinand E.
Massari is currently a Director at Clinical Trials Management Group, Inc. He previously worked as a Principal at Merck & Co., Inc., Pharmacia Corp., and Pfizer Ltd.
He also served as the Chief Medical Officer & SVP-Drug Development at Coley Pharmaceutical Group, Inc., Chief Medical Officer at to-BBB technologies BV, and Chief Medical Officer & Senior VP-Development at ImmusanT, Inc. Additionally, he was a Faculty Member at the University of Pennsylvania.
Massari received his undergraduate degree from the University of Maryland and his doctorate from Sidney Kimmel Medical College.
Postes actifs de Ferdinand E. Massari
| Sociétés | Poste | Début |
|---|---|---|
Clinical Trials Management Group, Inc.
 Clinical Trials Management Group, Inc. Hospital/Nursing ManagementHealth Services Clinical Trials Management Group, Inc. provides clinical trial systems for private practice physicians. The firm provides the functional expertise, controlled systems, and personnel for physician to conduct clinical trials on patients. The company was founded by Anton-Lewis Usala in April 2004 and is headquartered in Greenville, NC. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ferdinand E. Massari
| Sociétés | Poste | Fin |
|---|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Directeur Technique/Scientifique/R&D | 03/05/2011 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Corporate Officer/Principal | 01/01/2005 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/01/2003 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1998 |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Directeur Technique/Scientifique/R&D | - |
Formation de Ferdinand E. Massari
| Sidney Kimmel Medical College | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Clinical Trials Management Group, Inc.
Clinical Trials Management Group, Inc. Hospital/Nursing ManagementHealth Services Clinical Trials Management Group, Inc. provides clinical trial systems for private practice physicians. The firm provides the functional expertise, controlled systems, and personnel for physician to conduct clinical trials on patients. The company was founded by Anton-Lewis Usala in April 2004 and is headquartered in Greenville, NC. | Health Services |
